Oxford Finance, Square 1 Provide Facility to Tarsa
Tarsa Therapeutics said it has secured a $10 million senior secured facility from Oxford Finance and Square 1 Bank.
Tarsa Therapeutics said it has secured a $10 million senior secured facility from Oxford Finance and Square 1 Bank.
Oxford Finance announced the closing of an $8 million senior secured term loan agreement with Natrix Separations. Proceeds of the loan will be used for working capital.
Oxford Finance closed an $8 million senior secured term loan agreement with Natrix Separations. Proceeds of the loan will be used for working capital.
Oxford Finance announced the closing of a $30 million senior secured term loan agreement with Radius Health. The financing was provided to Radius Health from both Oxford and Solar Capital.
Cerus announced it entered into a $30 million growth capital credit facility with Oxford Finance.
Tobira Therapeutics announced that it closed a four year, $15 million term loan facility with Oxford Finance.
Specialty pharmaceutical company DURECT said it has entered in a $20 million term loan agreement with Oxford Finance at a fixed interest rate of 7.95%.
Oxford Finance announced that a $6.1 million round of financing was provided to Synergy Health Centers. Proceeds of the loan will be used to acquire the Park Avenue Health Center in Arlington, MA.
Oxford Finance closed a $4 million debt facility with IntelliCyt. Proceeds of the loan will be used for working capital and to support the company’s product development and marketing initiatives.
Ceterix Orthopaedics closed $18 million in new financing. Silicon Valley Bank and Oxford Finance joined the company’s investors in the debt financing, which support commercial expansion of the company’s products.